Overview

Perineural Low-dose Dexamethasone Added to Infraclavicular Block Anesthesia

Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Dexamethasone has an evidence-based indication in postoperative emesis prophylaxy and as a antiinflammatory steroid. Although the perineural administration is off-label, several studies recognised its analgetic action as an adjuvant for peripheral nerves blockade, permitting to reduce the concentration of the local anesthetics and extending the sensory and motor block.Questions remain concerning the mechanism of action, optimal dose, the lack/degree of toxicity and the comparison with intravenous administration.The aim of this prospective randomized controlled study is to investigate the efficacy of analgesia with 4 mg or 2 mg Dexamethasone added to a combination of ropivacaine 0,5% and lidocaine 1% in vertical infraclavicular blockade (VIB) anesthesia for upper limb surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Foisor Orthopedics Clinical Hospital
Treatments:
Acetaminophen
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Lidocaine
Morphine
Ropivacaine